» Articles » PMID: 2622760

Sensitization of Articular Afferents to Mechanical Stimuli by Bradykinin

Overview
Journal Pflugers Arch
Specialty Physiology
Date 1989 Dec 1
PMID 2622760
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

In 18 cats anaesthetized with alpha-chloralose, we recorded from thin myelinated and unmyelinated articular afferents of the medial articular nerve of the knee joint. Bradykinin was injected intra-arterially close to the knee, alone and in combination with prostaglandin E2 (PGE2), and changes of the responses of single afferents to movements of the knee were monitored. Bradykinin changed the mechanosensitivity in 20 of 28 afferents inducing movement sensitivity in initially unresponsive units, lowering the threshold for movements in high-threshold afferents and/or enhancing pre-existing responses to innocuous and/or noxious joint movements in low and high threshold units. Also the application of PGE2 and bradykinin within a short interval sensitized the majority of these afferents, and in about 50% of the afferents the effect of the combination was superior to those induced by the single substances. We conclude that the inflammatory mediator bradykinin is able to sensitize articular afferents for movement stimuli and that PGE2 may enhance this effect. It is suggested that in arthritis inflammatory mediators act synergistically in the initiation and stabilization of the increased mechanosensitivity of slowly conducting articular afferents.

Citing Articles

Targeting Proteinase Activated Receptor-4 Reduces Mechanonociception During the Acute Inflammatory Phase but not the Chronic Neuropathic Phase of Osteoarthritis in Rats.

OBrien M, McDougall J Front Pharmacol. 2022; 12:756632.

PMID: 35002698 PMC: 8727523. DOI: 10.3389/fphar.2021.756632.


VGF: a biomarker and potential target for the treatment of neuropathic pain?.

Soliman N, Okuse K, Rice A Pain Rep. 2019; 4(5):e786.

PMID: 31875189 PMC: 6882576. DOI: 10.1097/PR9.0000000000000786.


Profound alteration in cutaneous primary afferent activity produced by inflammatory mediators.

Smith-Edwards K, Deberry J, Saloman J, Davis B, Woodbury C Elife. 2016; 5.

PMID: 27805567 PMC: 5117853. DOI: 10.7554/eLife.20527.


Differential contributions of A- and C-nociceptors to primary and secondary inflammatory hypersensitivity in the rat.

Hsieh M, Donaldson L, Lumb B Pain. 2015; 156(6):1074-1083.

PMID: 25760474 PMC: 4535358. DOI: 10.1097/j.pain.0000000000000151.


Protease-activated receptor 4: a critical participator in inflammatory response.

Fu Q, Cheng J, Gao Y, Zhang Y, Chen X, Xie J Inflammation. 2014; 38(2):886-95.

PMID: 25120239 DOI: 10.1007/s10753-014-9999-6.


References
1.
Levine J, Lau W, Kwiat G, Goetzl E . Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science. 1984; 225(4663):743-5. DOI: 10.1126/science.6087456. View

2.
Grigg P, Schaible H, Schmidt R . Mechanical sensitivity of group III and IV afferents from posterior articular nerve in normal and inflamed cat knee. J Neurophysiol. 1986; 55(4):635-43. DOI: 10.1152/jn.1986.55.4.635. View

3.
Kumakura S, Kamo I, Tsurufuji S . Role of bradykinin in the vascular permeability response induced by carrageenin in rats. Br J Pharmacol. 1988; 93(4):739-46. PMC: 1853887. DOI: 10.1111/j.1476-5381.1988.tb11457.x. View

4.
Steranka L, Manning D, Dehaas C, Ferkany J, Borosky S, Connor J . Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A. 1988; 85(9):3245-9. PMC: 280181. DOI: 10.1073/pnas.85.9.3245. View

5.
Lim R . Pain. Annu Rev Physiol. 1970; 32:269-88. DOI: 10.1146/annurev.ph.32.030170.001413. View